共 38 条
[31]
Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K., Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study, JAMA, 264, pp. 2511-2518, (1990)
[32]
Rohdich R., Kirste A., Ein integrierter Behandlungsansatz für schizophrene Patienten mit Suchterkrankung und Persönlichkeitsstörung in der Klinik für Forensische Psychiatrie Haina, Recht Psychiatr, 23, pp. 116-122, (2005)
[33]
Rubio G., Martinez I., Ponce G., Jimenez-Arriero M.A., Lopez-Munoz F., Alamo C., Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity, Can J Psychiatry, 51, pp. 531-539, (2006)
[34]
Sayers S.L., Campbell E.C., Kondrich J., Mann S.C., Cornish J., O'Brien C., Caroff S.N., Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol, J Nerv Ment Dis, 193, pp. 379-386, (2005)
[35]
Schnell T., Neisius K., Daumann J., Gouzoulis-Mayfrank E., Prävalenz der Komorbidität Psychose und Sucht – Klinisch-epidemiologische Ergebnisse aus einer deutschen Großstadt, Nervenarzt, 81, pp. 323-328, (2010)
[36]
Schnell T., Koethe D., Krasnianski A., Gairing S., Schnell K., Daumann J., Gouzoulis-Mayfrank E., Ziprasidone vs. Clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study, Am J Addict, 23, pp. 308-312, (2014)
[37]
Stuyt E.B., Sajbel T.A., Allen M.H., Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders, Am J Addict, 15, pp. 166-173, (2006)
[38]
Ziedonis D.M., D'Avanzo K., Schizophrenia and Substance abuse, Dual diagnosis and treatment, pp. 427-465, (1998)